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Human immunodeficiency virus-1 Tat protein and human Cyclin T1 mediate transcriptional activation by enhancing the
elongation efficiency of RNA polymerase II. Activation of transcription of the related equine infectious anemia virus (EIAV)
requires a similar protein known as eTat, which does not function in human cells. Expression of equine Cyclin T1 in human
cells rescues eTat function, suggesting a general mechanism of transcription activation among lentiviruses. Here we present
the cloning of Cyclin T1 from canine D17 osteosarcoma cells, which support EIAV transactivation, and show that canine
Cyclin T1 confers eTat transactivation to human cells. A two-amino-acid change, from 79–proline–glycine–80 to 79–histidine–
arginine–80, confers on the human Cyclin T1 the ability to cooperate with eTat in transcriptional activation. These findings
suggested that the regions of Cyclin T1 that interact with lentiviral Tat proteins and TAR RNA elements form an extended
domain, which very likely has a conserved fold. © 2000 Academic PressIntroduction. Human immunodeficiency virus type 1
(HIV-1) encodes a Tat protein, which trans activates tran-
scription of the viral long terminal repeat (LTR) (1, 2). Tat
binds to the trans-activating response (TAR) RNA ele-
ment found at the 59 end of all viral transcripts (1, 2).
Genetic analysis of HIV-1 Tat (hTat) suggests that this
protein needs cellular cofactors to productively bind to
the TAR element in vivo (3, 4). It was determined that
cyclin-dependent kinase-9 (Cdk 9)-associated cyclin,
termed Cyclin T1, interacts with the hTat protein and
mediates specific binding of Tat to the TAR element (5).
Cyclin T1 is a component of the positive transcription
elongation factor b (P-TEFb) (6), which is thought to
stimulate RNA polymerase II (RNAPII) elongation via hy-
perphosphorylation of the carboxy-terminal domain
(CTD) of the largest subunit of the polymerase (5, 7). hTat
interaction with human Cyclin T1 is necessary for pro-
ductive binding to the TAR element and is believed to
recruit the human P-TEFb to RNA pol II leading to effi-
cient elongation of viral transcripts (5, 8). Equine Infec-
tious Anemia Virus (EIAV), a distantly related lentivirus
(7), encodes a Tat protein (eTat) that acts to enhance
transcription via an RNA element (eTAR). Although eTat
is insufficient to trans activate EIAV LTR transcription in
human cells, it can squelch hTat trans activation of the
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7HIV-1 LTR (3, 4). Experiments using chimeras of these Tat
proteins and of the respective retroviral LTRs have
proven that eTat and hTat have similar activation do-
mains (9). These findings led to the hypothesis that the
cellular cofactor responsible for eTat action would be a
homolog of human Cyclin T1 (hCycT1) (4, 9). This hypoth-
esis has been proven recently; expression of equine
Cyclin T1 (eCycT1) rescues eTat action in human cells
(2). eTat and hTat share the ability to trans activate their
respective LTRs in D17 canine osteosarcoma cells, sug-
gesting that canine Cyclin T1 would be capable of form-
ing productive complexes with both viral proteins. We
have cloned the Cyclin T1 gene from canine D17 cells
and determined that this protein confers eTat trans acti-
vation to a human cell line, thus extending the findings of
Bieniasz et al. (2). Comparison of the primary sequence
of equine and canine Cyclin T1 (cCycT1) suggested the
identity of amino acids near the n-terminus of eTat that
are critical for transactivation of the EIAV LTR. Moreover
we show that a two-amino-acid change from proline–
glycine to histidine–arginine at positions 79 and 80 con-
fers on the human Cyclin T1 the ability to cooperate with
eTat in transcriptional activation.
Results. Canine D17 cells support trans activation of
both HIV-1 and EIAV LTRs by hTat and eTat, respectively,
and are considered a good model system to study acti-
vation by these viral proteins (Fig. 1). D17 cells were
cotransfected with plasmids encoding hTat or K41A
(a nonfunctional hTat mutant) proteins, the HIV-1 LTR
0042-6822/00 $35.00
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8 RAPID COMMUNICATIONdriving a chloramphenicol acetyl-transferase (CAT) gene
(HIV-1 LTR-CAT), or eTat or R34G (a nonfunctional eTat
mutant) and the EIAV LTR driving a CAT gene (EIAV
LTR-CAT). As expected, hTat and eTat trans activation
was observed in D17 cells for HIV-1 and EIAV LTRs,
respectively (Fig. 1).
HCycT1, eCycT1, and murine cyclin T1 (mCycT1) are
very highly conserved, suggesting that cyclin T1 proteins
from other mammalian species should also show high
degree of sequence homology (8). RT/PCR was used to
obtain a cDNA clone encoding the entire 725-amino-acid
open reading frame of cCycT1. Sequence comparisons
revealed hCycT1 and cCycT1 to be 94% identical and
mCycT1 and cCycT1 to be 91% identical (Fig. 2). The
equine and the canine proteins are conserved to an even
more remarkable degree; the critical first 273 amino
acids are identical (Fig. 2). Comparison of the Tat:TAR
recognition motif (TRM) between hCycT1 and cCycT1
revealed conservation of the cysteine at position 261,
which is known to be critical for a productive interaction
of hCycT1–hTat to TAR (8, 10). This conservation of
cys261 was expected given that D17 cells support acti-
vation by hTat.
Human 293T cells are permissive for hTat trans acti-
ation of the HIV LTR, but are unable to support eTat
rans activation of the EIAV LTR. Given that the first 300
FIG. 1. D17 cells support activation of both HIV-1 and EIAV. D17 cells
plasmid and the indicated Tat expression plasmids. CAT activity was
represent the average of two experiments. For the EIAV LTR -Tat, basamino acids from the amino-terminal end of hCyc T1 are
ufficient to support trans activation by hTat (8), we
(
iloned a cDNA engineered to direct expression of the
irst 313 amino acids of cCycT1. To test for rescue of eTat
rans activation, pCGN-cCycT1 was cotransfected into
uman 293T cells with plasmids that express eTat and
IAV LTR-CAT. Not surprisingly, overexpression of
CycT1 (1-313) did not rescue trans activation of the EIAV
LTR in 293T cells (Table 1); the pCGN vector alone also
failed to rescue trans activation of EIAV LTR (data not
hown). In contrast, cCycT1 (1-313) was able to rescue
Tat trans activation of EIAV LTR in human 293T cells
Table 1). It is important to note that overexpression of
CycT1 did not affect CAT activity in the absence of eTat
Table 1).
Bieniasz et al. have shown that the first 134 amino
cids of eCycT1 encode critical determinants for eTat
unction not found in hCycT1 residues 1-134 (2). Com-
arison of this region from the the four Cyclin T1 proteins
n Fig. 2 and evaluation of the activity of these proteins
uggested the importance of specific residues. Leu29
nd Ala110 in cCycT1 and eCycT1 are substituted in
CycT1 by Val29 and Thr110. Amino acids 79–80 are
ifferent in hCycT1 when compared to the other three
ycT1 proteins shown in Fig. 2. In order to identify
esidues that are critical for eTat activation we made the
ollowing changes in hCycT1: Val29 3 Leu29 (M1), or
ro79Gly80 3 His79Arg80 (M2), or Ala110 3 Thr110
otransfected with the (A) HIV-1 LTR-CAT and (B) EIAV LTR-CAT reporter
ated after subtracting activity for mock-transfected cells. The values
activity was very close to mock.M3). The mutated proteins were tested for eTat activity
n 293T cells. The changes at positions 79 and 80 were
yclin T1
9RAPID COMMUNICATIONsufficient to make hCyc T1 compatible with eTat,
whereas the other changes had no effect on activity (Fig.
FIG. 2. Predicted amino acid sequence of human Cyclin T1, canine
in the predicted sequences of human Cyclin T1, murine Cyclin T1, and c
Cyclin T1, which is critical for hTat binding, is conserved in the canine C
changed in the experiment presented in Fig. 3.3). Thus, a two-amino-acid difference confers on hCyc T1
the ability to interact productively with eTat and eTAR.These data provide strong support for the idea that
cCycT1 can confer to human cells the ability to respond
T1, equine Cyclin T1, and murine Cyclin T1. Homologous amino acids
yclin T1 are boxed together. The cysteine at position 261 of the human
and is indicated by an asterisk. M1, M2, and M3 indicate the positionsCyclin
anine Cto eTat, thus extending and confirming the work of Bie-
nasz et al. on the equine cCyc T1 (2). This makes it
i
numb
10 RAPID COMMUNICATIONalmost a foregone conclusion that the canine homolog
of Cyclin T1 is the eTat cofactor in D17 cells. These
studies argue that a cyclin T1-mediated mechanism
of transcriptional control was probably acquired by a
common progenitor of HIV-1 and EIAV. Our mutational
analysis indicates that the N-terminal region of the
T
Canine Cyclin T1 Promotes eTat Tran
pCGN-hCycT1 (1–313):
pCGN-cCycT1 (1–313):
1 ng 25 ng
pc-eTat: 2 1 2 1 2
Exp. 1 14 22 25 16 11
Exp. 2 4 6 5 6 4
Exp. 3 16 17 19 22 11
a EIAV LTR-CAT plasmid was cotransfected with pCGN-hCycT1(1–3
ndicated by a “1” 10 ng of pc-eTat was also cotransfected. Bluesc
Overexpression of human Cyclin T1 was used as a negative control. The
Values are the averages of duplicate transfections.
FIG. 3. A two-amino-acid change at positions 79 and 80 confers on h
the indicated eTat expression plasmids were cotransfected with plasmi
CAT activity was calculated after subtracting activity for mock-transfected cell
which was repeated three times with almost identical results.CycT1 is critical for interaction with eTat. We inter-
pret this to suggests that the overall fold of the CycT1
domain that interacts with Tat and TAR is encoded by a
region much larger than the TRM, and is conserved
among lentiviruses (for an alternative interpretation see
Biesnaz (2)).
ation of the EIAV LTR in 293T Cellsa
5 ng 10 ng 25 ng
1 2 1 2 1 2 1
164 14 223 12 205 15 140
88 3 165 4 139 4 112
246 11 365 9 252 13 286
pCGN-cCycT1(1–313) into 293T cells as described in the text. Were
A was used to bring the total transfected DNA to 2 mg per well.
ers represent CAT activity (in cpm/min) normalized to luciferase activity.
the ability to collaborate with eTat. EIAV LTR-CAT reporter plasmid and
essing either cCyc T1, hCyc T1, or mutants of hCyc T1 (M1, M2, or M3).ABLE 1
sactiv
1 ng
13) or
ript DNCyc T1
ds exprs. The values represent the average of duplicates for one experiment,
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11RAPID COMMUNICATIONMaterials and Methods. In the experiment presented
n Fig. 1 cells were cotransfected with a plasmid in which
uciferase was expressed using a herpes simplex virus–
hymidine kinase promoter (HSV-TK-luc). Plasmids were
ixed with 5 ml of lipofectamine (Gibco BRL) in Dulbecco
modified Eagle’s medium (DMEM) and incubated with
the D17 cells for 6 h. The medium was replaced with
DMEM containing 10% fetal bovine serum (FBS) and 1%
penicillin/streptomycin and the cells were harvested 24 h
later. CAT and luciferase activity, normalized for total
protein, were measured as described before (11, 12).
Primer sets for RT/PCR (59-ATGGAGGGAGAGAG GAA-
GAA-39, 59-AGCATATTCACAGTGTCTTG-39 and 59-GAA-
AAGCACAAGACTCACC-39 C, 59-TTACTTAGGAAGGGGT-
GGAAGTG-39) were designed based on the sequence of
hCyclin T1 and were used to clone by RT/PCR the entire
725-amino-acid open reading frame of the canine Cyclin
T1 (cCyclin T1) from total RNA from D17 cells. Given that
the first 300 amino acids, from the amino-terminal end, of
hCyclin T1 are sufficient to support trans activation by
hTat (8), we used primers (59-GCGCTCTTAGAATGGAGG-
GAGAGAGGAAGAA-39 and 59-CCGGCCGGGGATCCC-
AGGGAAGGCACTGCACTTG-39) to clone a cDNA encod-
ing the first 313 amino acids of cCyclin T1. This was
inserted into the pCGN vector (10) at the XbaI and BamHI
sites to give pCGN-cCycT1 (1-313). To express mutant
hCyc T1 proteins M1, M2, and M3 primers were designed
for PCR mediated site-directed mutagenesis as indi-
cated in the text. PCR products were digested with DpnI
and plasmids were sequenced to confirm mutagenesis.
Transfections consisted of 500 ng of EIAV LTR-CAT,
200 ng of the HSV-TK-luc (11, 12), and different amounts
of pCGN-cCycT1 (1-313) or pcGN-hCycT1 (1-313) as a
control. Transfections were conducted using 5 ml of li-
ofectamine (Gibco BRL) in DMEM. Five hours after the
93T cells were incubated with lipofectamine, the me-
ium was replaced with DMEM containing 10% FBS and
% penicillin/streptomycin. Cells were harvested 48 h
ater. CAT and luciferase activity per mg protein were
easured as demonstrated before (11, 12).
ACKNOWLEDGMENTS
We thank Bryan R. Cullen and Paul Bieniasz for sharing of data and
reagents before publication. We also thank B. M. Peterlin for sharing
data before publication. We thank members of the Garcia-Blanco lab-
oratory, most especially Carles Sun˜e and Aaron Goldstrohm for advice
and critical reading of the manuscript. We are grateful to Katherine
Jones, Bryan R. Cullen, Britta Wahren, and David Derse for plasmids
and other valuable reagents. This work was supported by a grant from
the NIH to M.A.G-B and by funds provided by the Center for AIDS
Research at Duke University Medical Center. LHL was supported by a
Howard Hughes Medical Institute Fellowship for Medical Students.Note added in proof. Recently the laboratory of B. M. Peterlin cloned
cDNAs encoding Cyc T1 from canine and equine cells and showed that
these gene products can confer eTat activation in human cells (B. M.
Peterlin, pers. commun.). The sequences of these cDNAs differ from
those that we obtained for cCycT1 (this article) and from those obtained
by Bieniasz et al. (3) for eCycT1. In addition, Peterlin and colleagues
claim that in the context of eCycT1 position 29 is critical for function.
The reasons for these differences are not immediately apparent.
REFERENCES
1. Bieniasz, P. D., Grdina, T. A., Bogerd, H. P., and Cullen, B. R. (1998).
Recruitment of a protein complex containing Tat and cyclin T1 to
TAR governs the species specificity of HIV-1 Tat. EMBO J. 17,
7056–7065.
2. Bieniasz, P. D., Grdina, T. A., Bogerd, H. P., and Cullen, B. R. (1999).
Highly divergent lentiviral Tat proteins activate viral gene ex-
pression by a common mechanism. Mol. Cell Biol. 19(7), 4592–
4599.
3. Carroll, R., Martarano, L., and Derse, D. (1991). Identification of
lentivirus Tat functional domains through generation of equine
infectious anemia virus/human immunodeficiency virus type 1
tat gene chimeras. J. Virol. 65, 3460–3467.
4. Carroll, R., Peterlin, B. M., and Derse, D. (1992). Inhibition of human
immunodeficiency virus type 1 Tat activity by coexpression of
heterologous trans activators. J. Virol. 66, 2000–2007.
5. Cullen, B. R. (1998). HIV-1 auxiliary proteins: making connections in
a dying cell. Cell 93, 685–692.
6. Dorn, P., DaSilva, L., Martarano, L., and Derse, D. (1990). Equine
infectious anemia virus tat: Insights into the structure, function
and evolution of lentivirus trans-activator proteins. J. Virol. 64,
1616–1624.
7. Jones, K. A. (1997). Taking a new TAK on Tat transactivation. Genes
Dev. 11, 2593–2599.
8. Garber, M. E., Wei, P., KewalRamani, V. N., Mayall, T. P., Herrmann,
C. H., Rice, A. P., Littman, D. R., and Jones, K. A. (1998). The
interaction between HIV-1 Tat and human cyclin T1 requires zinc
and a critical cysteine residue that is not conserved in the
murine CycT1 protein. Genes Dev. 12, 3512–3527.
9. Madore, S. J., and Cullen, B. R. (1993). Genetic analysis of the
cofactor requirement for human immunodeficiency virus type 1
Tat function. J. Virol. 67, 3703–3711.
0. Tanaka, M., and Winship, H. (1990). Differential transcription acti-
vation by Oct-1 and Oct-2: Interdependent activation domains
induce Oct-2 phosphorylation. Cell 60, 375–386.
1. Sune, C., Hayashi, T., Liu, Y., Lane, W. S., Young, R. A., and Garcia-
Blanco, M. A. (1997). CA150, a nuclear protein associated with
the RNA polymerase II holoenzyme, is involved in Tat-activated
human immunodeficiency virus type 1 transcription. Mol. Cell
Biol. 17, 6029–6039.
2. Sune, C. and Garcia-Blanco, M. A. (1999). Transcriptional cofactor
CA150 regulates RNA polymerase II elongation in a TATA-box-
dependent manner. Mol. Cell Biol. 19, in press.
3. Peng, J., Zhu, Y., Milton, J. T., and Price, D. H. (1998). Identification of
multiple cyclin subunits of human P-TEFb. Genes Dev. 12, 755–
762.
4. Wei, P., Garber, M. E., Fang, S., Fischer, W. H., and Jones, K. A.
(1998). A novel CDK9-associated C-type cyclin interacts directly
with HIV-1 Tat and mediates its high-affinity, loop-specific bind-
ing to TAR RNA. Cell 92, 451–462.
